Bond Bayris 4.7% ( USU07265AZ15 ) in USD
Issuer | Bayris |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 4.7% per year ( payment 2 times a year) |
Maturity | 14/07/2064 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 23 171 000 USD |
Cusip | U07265AZ1 |
Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) |
Moody's rating | N/A |
Next Coupon | 15/01/2026 ( In 122 days ) |
Detailed description |
Bayer is a multinational pharmaceutical and life science company with core businesses in pharmaceuticals, consumer health, and agricultural products. A detailed analysis of the current financial landscape reveals a specific bond offering from Bayer AG, a prominent global life sciences company with core competencies in healthcare and agriculture, widely recognized for its diverse portfolio spanning pharmaceuticals, consumer health, and crop science, which bond, identified by ISIN USU07265AZ15 and CUSIP U07265AZ1, was initially issued in the United States and is presently trading at 73.348% of its par value in USD, yielding a 4.7% interest rate with semi-annual payment frequency, being part of a total issuance volume of 23,171,000 units and available for a minimum purchase of 2,000 units, while notably featuring an extended maturity date of July 14, 2064, and carrying a BBB credit rating from Standard & Poor's (S&P). |